Harvest Health & Recreation Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
– Total revenue increased 98% to $231.5 million in 2020 from $116.8 million in 2019
– Fourth quarter revenue was $69.9 million , up 85% from the fourth quarter 2019 and 13% sequentially
– Net loss before non-controlling interest for the full year was $59.6 million compared to $168.8 million in 2019
– Total adjusted EBITDA was $15.3 million in 2020, compared to negative $43.7 million in 2019
– 2021 revenue target of $380 million introduced
– First quarter 2021 revenue target of at least $87 million compared to $45 million in the first quarter 2020
PHOENIX , March 30, 2021 /PRNewswire/ — Harvest Health & Recreation Inc. (“Harvest” or the “Company”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today reported its financial and operating results for the fourth quarter and year ended 2020. All financial information is provided in U.S. dollars unless otherwise indicated.
Fourth Quarter and Full Year 2020 Financial Results
- Total revenue in the fourth quarter was $69.9 million , an increase of 85% from $37.8 million in the fourth quarter of 2019, and up 13% compared to $61.6 million in the third quarter of 2020. Full year revenue increased 98% to $231.5 million in 2020 compared to $116.8 million in 2019.
- Gross profit in the fourth quarter was $31.3 million , compared to $16.6 million in the fourth quarter of 2019, and $28.7 million in the third quarter of 2020. Gross profit for the full year was $101.6 million compared to $41.1 million in 2019.
- Gross profit margin in the fourth quarter was 44.8%, compared to 43.8% in the fourth quarter of 2019, and 46.6% in the third quarter of 2020. Gross profit margin for the full year was 43.9% compared to 35.2% in 2019.
- Net loss before non-controlling interest was $7.4 million for the fourth quarter, compared to $85.2 million in the fourth quarter of 2019. Net loss before non-controlling interest for the full year was $59.6 million compared to $168.8 million in 2019.
- Adjusted EBITDA in the fourth quarter was $9.1 million , compared to ($8.8) million in the fourth quarter of 2019 and $11.5 million in the third quarter of 2020. Adjusted EBITDA for the full year was $15.3 million compared to ($43.7) million in 2019.
Please see the supplemental information regarding the use of Non-GAAP Financial Measures, and a reconciliation of Non-GAAP Financial Measures.
Fourth Quarter 2020 Business Highlights
- During the fourth quarter of 2020, Harvest opened two new dispensaries in Camp Hill and King of Prussia, Pennsylvania .
- On October 2, 2020 , Harvest terminated the agreement to sell two California retail assets to Hightimes Holdings for $6 million in preferred stock.
- On October 28, 2020 , Harvest completed a bought deal financing raising gross proceeds of approximately $32.4 million including the overallotment option. Units sold in the offering were priced at Cd$2.26 per unit and included one subordinate voting share and one-half warrant. Each warrant has an exercise price of Cd$3.05 and duration of 30 months.
- On October 30, 2020 , Harvest completed the purchase and license transfer of THChocolate, LLC, including cannabis manufacturing licenses in Colorado . The consideration paid was immaterial.
- On November 2, 2020 , Harvest announced a settlement agreement with Devine Holdings. Under the terms of the agreement, Harvest acquired three vertical medical cannabis licenses in Arizona exchange for the repayment by Devine Holdings of an outstanding $10.45 million receivable owed to Harvest concurrently with the license acquisition.
- On November 3, 2020 , Arizona voters approved Prop 207, a ballot initiative to allow recreational cannabis consumption in Arizona .
- On November 13, 2020 , Harvest completed the divestiture of its ownership in dispensary and cultivation assets in Arkansas , with net cash proceeds to Harvest of $12.9 million .
- On November 20, 2020 , Harvest announced the settlement of a legal dispute with minority owners of Interurban Capital Group. Harvest canceled a total of 42,378.4 Multiple Voting Shares and received a $12 million secured promissory note with 7.5% interest and five-year maturity. Service agreements and call option agreements for Washington retail locations were cancelled.
- As of December 31, 2020 , Harvest owned, operated, or managed 38 retail locations in six states, including 15 open dispensaries in Arizona .
Full Year 2020 Business Highlights
- Capital raised for full year included $20 million of real estate backed debt, $21.3 million in senior secured debt, and $91.4 million in equity.
- Capital expenditures for year totaled $26.9 million .
- During 2020 Harvest completed the acquisitions of Arizona Natural Selections, Interurban Capital Group, and Franklin Labs .
- During 2020 Harvest divested a group of select California retail assets and Arkansas retail and cultivation assets.
Recent Developments
- On January 22, 2021 , Harvest recorded the first recreational cannabis sale in the state of Arizona at its Scottsdale location. Harvest began serving adult use customers in addition to medical patients at all 15 of its dispensaries on January 22 .
- On January 25, 2021 , Harvest announced the closing of a sale leaseback transaction with Innovative Industrial Properties, Inc. Harvest sold a 292,000 square foot facility for $23.8 million . Harvest will operate the cultivation and processing facility and expects to receive up to $10.8 million in tenant improvements.
- On February 22, 2021 , Harvest announced the divestiture of two medical marijuana dispensaries in Bismarck and Williston, North Dakota for an immaterial amount of cash.
- On March 15, 2021 , Harvest announced the settlement of its dispute with Falcon International, Inc. In accordance with the settlement terms, Harvest now owns a 10% equity stake in Falcon and received a ten year warrant to purchase up to 20% of the company’s shares at an exercise price of $1.91 per share.
Outlook
Harvest is introducing a full year 2021 revenue target of $380 million , including at least $87 million in revenue expected during the first quarter. We remain focused on improving the profitability of our business and we expect our gross margins will continue to trend upwards overall, with some fluctuations from quarter to quarter.
Management Commentary
“Our fourth quarter results and the initial success of recreational sales in Arizona demonstrate the efficacy of our strategy to make targeted investments in our core markets of Arizona , Florida , Maryland , and Pennsylvania ” said Chief Executive Officer Steve White . “We are focused on continuing to build on this positive momentum as we execute on our plan in 2021.”
Conference Call & Webcast
Harvest Health and Recreation Inc. will host a conference call and audio webcast with Chief Executive Officer Steve White and Chief Financial Officer Deborah Keeley , Tuesday March 30, 2021 at 5:00 PM Eastern Time .
Registration for this event is required. Please use this link to register:
http://www.directeventreg.com/registration/event/9090211
Following registration, an email confirmation will be sent including dial in details and unique conference call codes. Registration will remain open during the call however we recommend advance registration to access the event.
Fourth quarter results will be available at:
https://investor.harvesthoc.com/financials/default.aspx
The live conference call webcast and replay will be available at:
https://investor.harvesthoc.com/financials/default.aspx
HARVEST HEALTH & RECREATION INC. |
||||||||||
Consolidated Balance Sheets |
||||||||||
(Amounts expressed in thousands of United States dollars, except share and per share data) |
||||||||||
December 31, 2020 |
December 31, 2019 |
|||||||||
ASSETS |
||||||||||
Current assets: |
||||||||||
Cash and cash equivalents |
$ |
78,055 |
$ |
22,685 |
||||||
Restricted cash |
4,542 |
8,000 |
||||||||
Accounts receivable, net |
5,051 |
12,147 |
||||||||
Notes receivable, current portion |
21,556 |
47,768 |
||||||||
Related party notes receivable, current portion |
10,052 |
3,581 |
||||||||
Inventory, net |
36,862 |
27,987 |
||||||||
Other current assets |
5,280 |
4,788 |
||||||||
Total current assets |
161,398 |
126,956 |
||||||||
Notes receivable, net of current portion |
18,211 |
34,430 |
||||||||
Property, plant and equipment, net |
176,827 |
149,841 |
||||||||
Right-of-use assets for operating leases, net |
60,843 |
52,445 |
||||||||
Related party right-of-use assets for operating leases, net |
5,621 |
6,321 |
||||||||
Intangibles assets, net |
272,118 |
159,209 |
||||||||
Corporate investments |
19,091 |
— |
||||||||
Acquisition deposits |
50 |
3,645 |
||||||||
Goodwill |
116,041 |
84,596 |
||||||||
Assets held for sale |
6,585 |
2,444 |
||||||||
Other assets |
19,850 |
8,114 |
||||||||
TOTAL ASSETS |
$ |
856,635 |
$ |
628,001 |
||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||||
LIABILITIES |
||||||||||
Current liabilities: |
||||||||||
Accounts payable |
$ |
10,755 |
$ |
6,969 |
||||||
Other current liabilities |
28,896 |
22,029 |
||||||||
Contingent consideration, current portion |
17,985 |
13,764 |
||||||||
Income tax payable |
17,504 |
5,310 |
||||||||
Operating lease liability, current portion |
2,906 |
2,244 |
||||||||
Related party operating lease liability, current portion |
135 |
428 |
||||||||
Notes payable, current portion |
20,910 |
8,395 |
||||||||
Total current liabilities |
99,091 |
59,139 |
||||||||
Notes payable, net of current portion |
244,066 |
213,181 |
||||||||
Warrant liability |
20,908 |
5,516 |
||||||||
Operating lease liability, net of current portion |
58,637 |
48,731 |
||||||||
Related party operating lease liability, net of current portion |
5,595 |
5,533 |
||||||||
Deferred tax liability |
53,082 |
28,587 |
||||||||
Contingent consideration, net of current portion |
— |
16,249 |
||||||||
Total liabilities associated with assets held for sale |
718 |
— |
||||||||
Other long-term liabilities |
63 |
179 |
||||||||
TOTAL LIABILITIES |
482,160 |
377,115 |
||||||||
STOCKHOLDERS’ EQUITY |
||||||||||
Capital stock |
667,248 |
481,182 |
||||||||
Accumulated deficit |
(293,607) |
(233,977) |
||||||||
Stockholders’ equity attributed to Harvest Health & Recreation Inc. |
373,641 |
247,205 |
||||||||
Non-controlling interest |
834 |
3,681 |
||||||||
TOTAL STOCKHOLDERS’ EQUITY |
374,475 |
250,886 |
||||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ |
856,635 |
$ |
628,001 |
HARVEST HEALTH & RECREATION INC. |
||||||||||||||||
Consolidated Statements of Operations |
||||||||||||||||
(Amounts expressed in thousands of United States dollars, except share and per share data) |
||||||||||||||||
For the three months ended |
For the twelve months ended |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Revenue, net of discounts |
$ |
69,922 |
$ |
37,793 |
$ |
231,460 |
$ |
116,780 |
||||||||
Cost of goods sold |
(38,607) |
(21,224) |
(129,873) |
(75,636) |
||||||||||||
Gross profit |
31,315 |
16,569 |
101,587 |
41,144 |
||||||||||||
Expenses |
||||||||||||||||
General and administrative |
25,284 |
29,518 |
99,603 |
105,966 |
||||||||||||
Sales and marketing |
1,604 |
2,399 |
4,960 |
8,937 |
||||||||||||
Share-based compensation |
4,147 |
(1,420) |
22,495 |
17,695 |
||||||||||||
Depreciation and amortization |
2,017 |
1,123 |
7,920 |
5,360 |
||||||||||||
Fixed and intangible asset impairments |
664 |
16,977 |
664 |
16,977 |
||||||||||||
Total expenses |
33,716 |
48,597 |
135,642 |
154,935 |
||||||||||||
Operating loss |
(2,401) |
(32,028) |
(34,055) |
(113,791) |
||||||||||||
Other income (expense) |
||||||||||||||||
Gain (loss) on sale of assets |
12,266 |
(2,431) |
11,752 |
(2,313) |
||||||||||||
Other income (expense) |
6,962 |
(7,773) |
17,185 |
(8,286) |
||||||||||||
Fair value of liability adjustment |
(14,433) |
(1,457) |
(10,125) |
5,482 |
||||||||||||
Foreign currency gain (loss) |
19 |
(469) |
(63) |
(970) |
||||||||||||
Interest expense |
(13,123) |
(5,164) |
(38,612) |
(9,514) |
||||||||||||
Contract asset recovery (impairment) |
1,688 |
(35,098) |
(732) |
(35,098) |
||||||||||||
Loss before taxes and non-controlling interest |
(9,022) |
(84,420) |
(54,650) |
(164,490) |
||||||||||||
Income taxes |
1,482 |
(185) |
(3,650) |
(3,756) |
||||||||||||
Loss from continuing operations before non-controlling interest |
(7,540) |
(84,605) |
(58,300) |
(168,246) |
||||||||||||
Net income (loss) from discontinued operations, net of tax |
142 |
(568) |
(1,278) |
(568) |
||||||||||||
Net loss before non-controlling interest |
(7,398) |
(85,173) |
(59,578) |
(168,814) |
||||||||||||
Net income (loss) attributed to non-controlling interest |
2,159 |
696 |
(52) |
2,079 |
||||||||||||
Net loss attributed to Harvest Health & Recreation Inc. |
$ |
(5,239) |
$ |
(84,477) |
$ |
(59,630) |
$ |
(166,735) |
||||||||
Net income (loss) per share – basic and diluted |
$ |
(0.02) |
$ |
(0.29) |
$ |
(0.16) |
$ |
(0.59) |
||||||||
Attributable to Harvest Health and Recreation Inc. |
$ |
(0.01) |
$ |
(0.29) |
$ |
(0.17) |
$ |
(0.58) |
||||||||
Attributable to discontinued operations, net of tax |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||||
Weighted-average shares outstanding – basic and diluted |
382,489,611 |
288,919,231 |
354,757,211 |
286,626,553 |
Use of Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures as defined by the SEC. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with GAAP are included below. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP. Our management uses adjusted EBITDA to evaluate our operating performance and trends and make planning decisions. Our management believes adjusted EBITDA helps identify underlying trends in our business that could otherwise be masked by the effect of the items that we exclude. Accordingly, we believe that adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by our management in its financial and operational decision-making.
Reconciliation of Non-GAAP Financial Measures
The table below reconciles Net income (loss) to Adjusted EBITDA for the periods indicated.
For the three months ended |
For the twelve months ended December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Net loss (GAAP) before non-controlling interest |
$ |
(7,398) |
$ |
(85,173) |
$ |
(59,578) |
$ |
(168,814) |
||||||||
Add (deduct) impact of: |
||||||||||||||||
Net interest and other financing costs (1) |
13,194 |
5,328 |
39,013 |
10,198 |
||||||||||||
Income tax |
(1,482) |
185 |
3,650 |
3,756 |
||||||||||||
Amortization and depreciation (2) |
2,827 |
2,002 |
11,290 |
7,754 |
||||||||||||
Fixed and intangible asset impairments |
664 |
16,977 |
664 |
16,977 |
||||||||||||
(Gain) loss on assets |
(12,266) |
2,431 |
(11,752) |
2,313 |
||||||||||||
Fair value adjustment of liability |
14,433 |
1,457 |
10,125 |
(5,482) |
||||||||||||
Other (income) expense |
(6,962) |
7,773 |
(17,185) |
8,286 |
||||||||||||
Foreign currency (gain) loss |
(19) |
469 |
63 |
970 |
||||||||||||
Share-based compensation expense |
4,147 |
(1,420) |
22,495 |
17,695 |
||||||||||||
Contract asset (recovery) impairment |
(1,688) |
35,098 |
732 |
35,098 |
||||||||||||
Discontinued operations, net of tax |
(142) |
568 |
1,278 |
568 |
||||||||||||
Other expansion expenses (pre-open) |
3,648 |
2,658 |
12,719 |
9,770 |
||||||||||||
Transaction & other special charges |
136 |
2,894 |
1,830 |
17,200 |
||||||||||||
Adjusted EBITDA (non-GAAP) |
$ |
9,092 |
$ |
(8,753) |
$ |
15,344 |
$ |
(43,711) |
(1) |
Includes $71, $164, $401, and $684 of interest reported in cost of sales. |
(2) |
Includes $810, $879, $3,370, and $2,394 of depreciation reported in cost of sales. |
Forward-looking Statements
This press release contains “forward-looking statements,” within the meaning of United States and Canadian securities laws. Such statements reflect current estimates, expectations and projections about future events and involve risks and uncertainties relating to future events and Harvest’s performance, and actual events may differ materially from these forward looking statements, which may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions. These forward looking statements include, without limitation, statements regarding our expectations for 2021 financial performance and targeted revenue; prospects for revenue growth and profitability in our core markets and in the U.S. cannabis industry generally; our continued growth in retail dispensary openings, same store sales growth, recreational sales in Arizona , and expanded cultivation and manufacturing operations; the development of federal and state cannabis regulatory framework in the United States applicable to multi-state operators, including a delay in, or a failure to, federally decriminalize cannabis in the United States , as well as such frameworks in Harvest’s core markets; adverse changes in the application or enforcement of current laws, including those related to taxation; adverse changes in the public perception of cannabis; the effects of the weather, natural disasters, and health pandemics, including the novel coronavirus (COVID-19) on customer demand, Harvest’s supply chain as well as its consolidated results of operation, financial position and cash flows; the ability of Harvest to develop Harvest’s brand and meet its growth, revenue and profitability projections and objectives; its ability to generate sufficient cash flow to repay debt obligations and to fund operating expenses and future investment; the ability of Harvest to complete planned acquisitions that are accretive to its revenue; the ability of Harvest to obtain and/or maintain licenses to operate in the jurisdictions in which it operates or in which it expects or plans to operate; changes in general economic, business and political conditions, including changes in the financial markets, and, in particular, the ability of Harvest to raise debt and equity capital in the amounts and at the costs that it expects; the ability to locate and acquire suitable companies, properties or assets necessary to execute on Harvest’s business plans; the ability of Harvest to execute planned store openings and secure cannabis supply at appropriate amounts and cost; fluctuations in the prevailing prices for cannabis and cannabis products in the markets that Harvest operates in and sources supply; its ability to resolve existing and future litigation and arbitrations on acceptable terms; and increasing costs of compliance with extensive government regulation. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. In addition, even if the outcome and financial effects of the plans and events described herein are consistent with the forward-looking statements contained in this document, those results or developments may not be indicative of results or developments in subsequent periods.
Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements. Please see the heading “Risk Factors” in Harvest’s Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission and in Harvest’s Annual Information Circular, which was filed on SEDAR, both of which were filed on March 30, 2021 , and subsequent filings that Harvest makes with the Securities and Exchange Commission and SEDAR, for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. Harvest does not undertake to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.
About Harvest Health & Recreation Inc.
Headquartered in Tempe, Arizona , Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator. Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S. Harvest’s mission is to improve lives through the goodness of cannabis. We hope you’ll join us on our journey: https://harvesthoc.com
Facebook: @HarvestHOC
Instagram: @HarvestHOC
Twitter: @HarvestHOC
View original content to download multimedia: http://www.prnewswire.com/news-releases/harvest-health–recreation-inc-reports-fourth-quarter-and-full-year-2020-financial-results-301258927.html
SOURCE Harvest Health & Recreation Inc.
News Provided by PR Newswire via QuoteMedia
Cannabis - Will The Fortune 500 Join The Party?
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.
The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.
The Company has also granted restricted share unit grants, pursuant to the Company’s Restricted Share Unit plan, dated April 1, 2021, totaling 1,548,875 to certain eligible participants.
For further information, please contact:
Igal Sudman, Chairman, Chief Executive Officer and Corporate Secretary
Ayurcann Holdings Corp.
Tel: 416-720-6264
Email: igal@xtrx.ca
Investor Relations:
Ryan Bilodeau
Tel: 416-910-1440
Email: ir@ayurcann.com
About Ayurcann Holdings Corp.:
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
News Provided by GlobeNewswire via QuoteMedia
A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.
Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.
Keep reading to find out more cannabis highlights from the past five days.
Cannabis - Will The Fortune 500 Join The Party?
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
Tilray delays critical shareholder meeting
On Thursday (April 15), Tilray (NASDAQ:TLRY) announced it will be postponing its shareholder vote on the fate of its merger with Aphria (NASDAQ:APHA,TSX:APHA). It will take place on April 30 instead of April 16.
Neither cannabis company offered an explanation for the change. Tilray has asked shareholders to participate in this vote regardless of how many shares they may hold. “Tilray stockholders who have not already voted, or wish to change their vote, are strongly encouraged to do so,” the company said.
This news came days after Aphria shareholders overwhelmingly voted in favor of the business transaction, with a total of 99.38 percent of shareholders voting for the deal to continue. Confirmation from Aphria Chairman and CEO Irwin Simon indicated the partnership was en route to being complete.
This past week Aphria also released financial results for the third quarter of its 2021 fiscal year, in which the firm highlights the overall direction of the company with the Tilray deal.
“We expect to have a tremendous runway for long-term sustainable growth as we build upon our existing foundation in Canada and internationally by increasing the scale of our global operations,” Simon said in a statement.
Cannabis retailer celebrates digital trend
As part of a celebration for April 20, otherwise known as 420, Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) announced the dissemination of a non-fungible token (NFT) digital art piece.
Cannabis - Will The Fortune 500 Join The Party?
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
Bidding for the piece, named “Non-Fungible Toke“ started at a price of C$4.20. The retailer plans to donate the proceeds to two charities, Second Harvest and Less.
The latter is designed to counter the carbon footprint of blockchain technology, a common criticism drawn against the rise of NFTs and other novel technologies.
As of 11:00 a.m. EST on Friday (April 16), the NFT bid was up to C$169.11.
Cannabis company news
- The Valens Company (TSX:VLNS,OTCQX:VLNCF) issued its financial report for the first quarter of its 2021 fiscal year. In its results, the company highlights a net revenue uptick of 24.7 percent from the previous quarter, resulting in C$20 million for the period.
- Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF) closed a public offering of 5 million subordinate voting shares at a price of C$50 each for total gross proceeds of C$287.5 million. The company celebrated its financial position after an offering in January, which will lead to the pursuit of merger and acquisition targets.
- Australis Capital (CSE:AUSA,OTCQB:AUSAF) appointed Jason Dyck as its new chief science officer and chairman of the firm’s scientific advisory board. Dyck previously served as an executive at Aurora Cannabis (NASDAQ:ACB,TSX:ACB), leading the scientific efforts for the cannabis producer. “I look forward to providing AUSA with advice and direction in its scientific efforts towards bringing innovations to market with immediate and significant commercial appeal,” Dyck said.
- Truss Beverage, a cannabis drinks venture co-owned by Molson Coors Beverage Company (NYSE:TAP,TSX:TPX) and HEXO (NYSE:HEXO,TSX:HEXO), released the details of its new lineup of infused beverages. Six new drinks will become available around the summer and are intended to pair with the season.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Cannabis - Will The Fortune 500 Join The Party?
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
Trulieve Announces Expungement Programs in Several States as Part of 420 Celebration
Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.
During the month of April, Minardi Law has hosted expungment clinics and will be hosting two more as follows:
- Releaf Patient Appreciation Day, April 17 th ( Valrico )
- First Annual 4/20 Event ( St. Petersburg Beach )
At these clinics, an attorney will be present to review records and see if someone is eligible for a sealing or expungment of their records. As part of the events, Trulieve will be helping cover the costs for finger prints, legal fees, and court costs.
Trulieve is working with Minorities for Medical Marijuana (“M4MM”) to host a 4/20 Expungement Clinic, part of M4MM’s Project Clean Slate. This event will take place on Saturday, April 24, 2021 , from 9:30am – 4:30pm at Riviera Beach City Hall. Anyone seeking to take place in this event is required to register in advance at http://trulieve.cc/expungementpreregistration .
In addition, Trulieve is sponsoring the First Friday Series , a weekly virtual event from the Georgia Justice Project to help Georgia citizens with record restrictions, and is also sponsoring the Fellowship Presentation and Expungement Clinic being offered through CultivateEd and GBLS on Friday, April 23 from 3:00pm – 4:00pm . You can register for the Massachusetts expungement clinic in advance here: HTTPS://BIT.LY/2Q655KK
“Our mission as a company has always been to improve people’s lives,” said Trulieve CEO Kim Rivers . “We’ve always been dedicated to improving the communities we call home. Partnering with Minardi Law , Minorities for Medical Marijuana, Georgia Justice Project and CultivatED on these clinics was a simple decision for us; we encourage anyone seeking help with the expungement process to attend one of these clinics in your own state to start the process.”
For more information about Trulieve and the April expungment clinics, please visit www.Trulieve.com .
About Trulieve
Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also has operations in California , Massachusetts , Connecticut and Pennsylvania. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.
To learn more about Trulieve, visit www.Trulieve.com .
View original content: http://www.prnewswire.com/news-releases/trulieve-announces-expungement-programs-in-several-states-as-part-of-420-celebration-301270340.html
SOURCE Trulieve Cannabis Corp.
News Provided by PR Newswire via QuoteMedia
Cannabis - Will The Fortune 500 Join The Party?
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola
The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).
“With the vast number of dispensaries in California , we put a lot of effort into identifying the right ones that align with Houseplant’s values,” said Seth Rogen , Co-Founder of Houseplant. “The Apothecarium shares the same commitment to creating a strong consumer experience that we pride ourselves on and we are thrilled to bring our three initial strains to their stores in the Bay Area.”
Houseplant is launching with three flower strains, all of which will be available at The Apothecarium, including: Diablo Wind (sativa), Pancake Ice (sativa) and Pink Moon (indica). Like their founder’s groundbreaking film “Pineapple Express”, Houseplant strains are named after weather phenomena. Each strain will be sold in a custom tin.
“We are so proud to be one of the very first dispensaries in California to offer Houseplant to our customers,” said Ryan Hudson , CEO and co-founder of The Apothecarium. “Seth, Evan and everyone at Houseplant love and respect cannabis as much as we do. We simply cannot wait to share their beautiful and delicious flowers with our guests.”
“We’ve been working with the Houseplant team for more than a year and are grateful to have a partner that shares so many of our values, including an emphasis on cannabis education, quality, reform of cannabis laws and beautifully designed, recyclable packaging.”
“Seth has been hands-on during the process, spending time with our store managers to make sure they know the products and how much care has gone into vetting and selecting the best strains. We think our guests are going to love Houseplant.”
About The Apothecarium
The Apothecarium is recognized as one of the nation’s premier cannabis dispensaries, with an emphasis on education via in-depth one-on-one consultations from highly trained cannabis consultants. The company was founded by three first cousins and two family friends in 2011. Our dispensaries are known for providing educational events that are open to the public at no cost — and for welcoming seniors, first-time dispensary visitors, and people with serious medical conditions. The Apothecarium’s flagship San Francisco dispensary was named the best-designed dispensary in the country by Architectural Digest . Patients and customers may order at our dispensaries or online for pickup or delivery at apothecarium.com [apothecarium.com] .
The Apothecarium is committed to giving back to the communities we serve. We have donated more than $400,000 in cash to community groups and nonprofits — plus more than $300,000 worth of in-kind donations.
All Apothecarium dispensaries continue to implement safety measures to protect guests and team members. Protocols include strict social distancing inside and outside the dispensaries, a mask requirement for everyone inside the dispensaries, no contact check-in procedures and ongoing sanitizing throughout the day.
CA Licenses: C10-0000523-LIC; C10-0000522-LIC; C10-0000515-LIC, C10-0000738-LIC, C10-0000706-LIC
View original content: http://www.prnewswire.com/news-releases/houseplant-launches-at-the-apothecariums-california-dispensaries-301270397.html
SOURCE TerrAscend
News Provided by Canada Newswire via QuoteMedia
Cannabis - Will The Fortune 500 Join The Party?
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
MISSISSAUGA, Ontario TheNewswire – April 16, 2021 Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (CNSX:SIRE.CN) (“SIRE” or the “Company”) announces that Brian Nugent has resigned as a member of the Company’s board of directors (the “ Board ”). It has been a pleasure and a blessing to have worked with Brian Nugent over the past few years, his business acumen and tremendous experience will certainly be missed, SIRE wishes him nothing but the best in all his future endeavors.
About Sire Bioscience
SIRE is headquartered in Mississauga, Ontario with its wholly owned subsidiary PLANTFUEL® based in Denver, Colorado. SIRE is managed by a group of successful entrepreneurs who have extensive experience in the areas of consumer-packaged goods, manufacturing, logistics, and distribution. SIRE is a CPG life science company focused on the plant-based foods and supplements industry.
For additional information contact:
Sire Bioscience Inc.
Website: sirebioscience.com
Socials: @sirebioscience
Copyright (c) 2021 TheNewswire – All rights reserved.
News Provided by TheNewsWire via QuoteMedia